• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过甲状腺功能正常化降低甲状腺功能减退患者颈总动脉的动脉僵硬度。

Decrease of arterial stiffness at common carotid artery in hypothyroid patients by normalization of thyroid function.

作者信息

Nagasaki Toshiki, Inaba Masaaki, Kumeda Yasuro, Ueda Misako, Hiura Yoshikazu, Tahara Hideki, Ishimura Eiji, Onoda Naoyoshi, Ishikawa Tetsuro, Nishizawa Yoshiki

机构信息

Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.

出版信息

Biomed Pharmacother. 2005 Jan-Feb;59(1-2):8-14. doi: 10.1016/j.biopha.2004.11.001. Epub 2004 Dec 24.

DOI:10.1016/j.biopha.2004.11.001
PMID:15740929
Abstract

This study examined the effect of hypothyroidism on arterial stiffening and the effect of levothyroxine (l-T(4)) replacement. The arterial stiffness index beta (stiffness beta) and intima-media thickness (IMT), a parameter of arterial stiffening and thickening, respectively, were determined in common carotid artery (CCA) by ultrasonography in 30 hypothyroid patients before and after 1 year of normalization of thyroid function by l-T(4) replacement. Baseline CCA stiffness beta and IMT was significantly higher in the hypothyroid patients than in age- and sex-matched normal controls [9.46 +/- 0.93 vs. 8.02 +/- 0.91 (mean +/- SE); P < 0.05, 0.635 +/- 0.018 mm vs. 0.541 +/- 0.019 mm; P < 0.005, respectively]. In multivariate analysis, baseline stiffness beta was significantly associated with baseline levels of IMT (r = 0.457, P = 0.0311), FT(4) (r = -0.413, P = 0.0169), and a plasma vascular injury marker, von Willebrand factor (vWF) (r = 0.412, P = 0.0261). During 1 year of euthyroidism, 22 and 29 out of 30 patients showed significant decreases of stiffness beta and IMT to normal respective level, from 9.46 +/- 0.93 to 7.58 +/- 0.34 and from 0.635 +/- 0.018 to 0.552 +/- 0.015 mm, respectively. Change in stiffness beta during l-T(4) therapy correlated significantly in a negative manner with baseline levels of age (r = -0.465, P = 0.011) and IMT (r = -0.406, P = 0.029). Stiffness beta after but not before l-T(4) therapy showed a tendency towards a positive correlation with age. This study suggested that increases of arterial thickening, and plasma vWF, and a reduction in serum FT(4) might have an important role independently in the increased arterial stiffening in hypothyroid patients. Furthermore, it was demonstrated that sustained euthyroidism might have the potential to reverse arterial stiffening in addition to thickening in hypothyroid patients.

摘要

本研究探讨了甲状腺功能减退对动脉僵硬度的影响以及左甲状腺素(l-T4)替代治疗的效果。通过超声检查测定了30例甲状腺功能减退患者在接受l-T4替代治疗使甲状腺功能正常化1年前及1年后颈总动脉(CCA)的动脉僵硬度指数β(僵硬度β)和内膜中层厚度(IMT),后者分别是动脉僵硬度和增厚的一个参数。甲状腺功能减退患者的基线CCA僵硬度β和IMT显著高于年龄及性别匹配的正常对照者[分别为9.46±0.93与8.02±0.91(均值±标准误);P<0.05,0.635±0.018mm与0.541±0.019mm;P<0.005]。多因素分析显示,基线僵硬度β与基线IMT水平(r=0.457,P=0.0311)、游离甲状腺素(FT4)(r=-0.413,P=0.0169)以及血浆血管损伤标志物血管性血友病因子(vWF)(r=0.412,P=0.0261)显著相关。在甲状腺功能正常的1年期间,30例患者中有22例和29例的僵硬度β和IMT分别显著下降至正常水平,即从9.46±0.93降至7.58±0.34,从0.635±0.018降至0.552±0.015mm。l-T4治疗期间僵硬度β的变化与年龄(r=-0.465,P=0.011)和IMT的基线水平(r=-0.406,P=0.029)呈显著负相关。l-T4治疗后而非治疗前的僵硬度β显示出与年龄呈正相关的趋势。本研究提示,动脉增厚、血浆vWF升高以及血清FT4降低可能在甲状腺功能减退患者动脉僵硬度增加中各自发挥重要作用。此外,研究表明持续的甲状腺功能正常状态除了可逆转甲状腺功能减退患者的动脉增厚外,还可能逆转动脉僵硬度。

相似文献

1
Decrease of arterial stiffness at common carotid artery in hypothyroid patients by normalization of thyroid function.通过甲状腺功能正常化降低甲状腺功能减退患者颈总动脉的动脉僵硬度。
Biomed Pharmacother. 2005 Jan-Feb;59(1-2):8-14. doi: 10.1016/j.biopha.2004.11.001. Epub 2004 Dec 24.
2
Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery.甲状腺功能减退患者C反应蛋白水平升高及其与颈总动脉僵硬度的相关性。
Biomed Pharmacother. 2007 Feb-Apr;61(2-3):167-72. doi: 10.1016/j.biopha.2006.10.008. Epub 2007 Feb 21.
3
Plasma levels of adiponectin and soluble thrombomodulin in hypothyroid patients with normal thyroid function following levothyroxine replacement therapy.左甲状腺素替代治疗后甲状腺功能正常的甲状腺功能减退患者的血浆脂联素和可溶性血栓调节蛋白水平
Biomed Pharmacother. 2005 Dec;59(10):571-7. doi: 10.1016/j.biopha.2005.03.014. Epub 2005 Aug 10.
4
Change in von Willebrand factor and carotid intima-media thickness in hypothyroid patients with normal thyroid function after levothyroxine replacement therapy.左甲状腺素替代治疗后甲状腺功能正常的甲状腺功能减退患者血管性血友病因子及颈动脉内膜中层厚度的变化
Eur J Endocrinol. 2004 Feb;150(2):125-31. doi: 10.1530/eje.0.1500125.
5
Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.左甲状腺素替代疗法对原发性甲状腺功能减退症患者颈动脉内膜中层厚度的影响。
Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):294-300. doi: 10.1055/s-0028-1085998. Epub 2008 Sep 30.
6
Changes in brachial-ankle pulse wave velocity in subclinical hypothyroidism during normalization of thyroid function.亚临床甲状腺功能减退症患者甲状腺功能恢复正常过程中肱踝脉搏波速度的变化
Biomed Pharmacother. 2007 Sep;61(8):482-7. doi: 10.1016/j.biopha.2007.04.004. Epub 2007 May 21.
7
Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function.甲状腺功能正常化后甲状腺功能减退患者颈动脉内膜中层厚度的降低。
Clin Endocrinol (Oxf). 2003 Nov;59(5):607-12. doi: 10.1046/j.1365-2265.2003.01893.x.
8
Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults.健康成年人血清尿酸与内皮功能及动脉粥样硬化指标的关系。
Int J Clin Pract. 2005 Nov;59(11):1276-82. doi: 10.1111/j.1742-1241.2005.00621.x.
9
Increased levels of serum osteoprotegerin in hypothyroid patients and its normalization with restoration of normal thyroid function.甲状腺功能减退患者血清骨保护素水平升高及其随甲状腺功能恢复正常而恢复正常。
Eur J Endocrinol. 2005 Mar;152(3):347-53. doi: 10.1530/eje.1.01870.
10
[Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients].甲状腺功能减退患者左甲状腺素替代治疗前后骨保护素血浆浓度的变化
Zhonghua Yi Xue Za Zhi. 2007 Aug 14;87(30):2121-5.

引用本文的文献

1
Arterial Stiffness in Thyroid and Parathyroid Disease: A Review of Clinical Studies.甲状腺和甲状旁腺疾病中的动脉僵硬度:临床研究综述
J Clin Med. 2022 Jun 1;11(11):3146. doi: 10.3390/jcm11113146.
2
Is Stiffness Parameter β Useful for the Evaluation of Atherosclerosis?~ Its Clinical Implications, Limitations, and Future Perspectives ~.β 僵硬度参数在评估动脉粥样硬化方面有用吗?~ 其临床意义、局限性和未来展望~。
J Atheroscler Thromb. 2021 May 1;28(5):435-453. doi: 10.5551/jat.RV17047. Epub 2021 Feb 13.
3
Carotid Beta Stiffness Association with Thyroid Function.
颈动脉β硬度与甲状腺功能的关联
J Clin Med. 2021 Jan 22;10(3):420. doi: 10.3390/jcm10030420.
4
Thyroid Dysfunction and Atherosclerosis: A Systematic Review.甲状腺功能障碍与动脉粥样硬化:系统评价
In Vivo. 2020 Nov-Dec;34(6):3127-3136. doi: 10.21873/invivo.12147.
5
FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis.甲状腺功能减退症中 FABP4 水平及其与亚临床动脉粥样硬化的关系。
Turk J Med Sci. 2019 Oct 24;49(5):1490-1497. doi: 10.3906/sag-1904-41.
6
An assessment of the relationship between thyroid nodule characteristics, insulin resistance and arterial stiffness in euthyroid nodular goiter.评估甲状腺结节特征、胰岛素抵抗与甲状腺功能正常的结节性甲状腺肿患者动脉僵硬度的关系。
Endocrine. 2018 Nov;62(2):440-447. doi: 10.1007/s12020-018-1701-6. Epub 2018 Aug 6.
7
Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.甲状腺功能减退症和自身免疫性甲状腺疾病中的止血作用。
Int J Endocrinol Metab. 2017 Mar 9;15(2):e42649. doi: 10.5812/ijem.42649. eCollection 2017 Apr.
8
Serum free thyroxine levels are positively associated with arterial stiffness in the SardiNIA study.在撒丁岛研究中,血清游离甲状腺素水平与动脉僵硬度呈正相关。
Clin Endocrinol (Oxf). 2015 Apr;82(4):592-7. doi: 10.1111/cen.12532. Epub 2014 Jul 14.
9
Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.显性和亚临床甲状腺疾病患者的血脂异常与心脏代谢风险
J Lipids. 2011;2011:575840. doi: 10.1155/2011/575840. Epub 2011 Jul 18.